1014PDPhase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies
Jurczak, W, Rule, S, Townsend, W, Tucker, D, Sarholz, B, Scheele, J, Gribben, J, Zinzani, P LVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy286.010
Date:
October, 2018
File:
PDF, 94 KB
2018